Showing results (121-130 of 243) with videos related to
Sort By:
Pageof 25
Therapeutic Advances in Respiratory Disease|March 6, 2023
Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature reviewAyana Suzuki, Koichiro Kamio, Mitsuhiro Takeno, et al.Respiratory Medicine Case Reports|March 3, 2025
Allergic bronchopulmonary mycosis induced by pembrolizumab for bladder cancer: A case reportHiroki Iida, Kenichiro Atsumi, Naohiro Kadoma, et al.Translational Cancer Research|September 13, 2023
A remarkable response to combination chemotherapy with nivolumab and ipilimumab in a patient with primary pulmonary choriocarcinoma: a case reportHirokazu Iso, Kakeru Hisakane, Naoki Terashi, et al.Future Oncology (London, England)|January 17, 2022
Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901)Yusuke Okuma, Mototsugu Shimokawa, Kana Hashimoto, et al.Thoracic Cancer|May 17, 2022
The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non-small cell lung cancerMasamitsu Shimizu, Akihiko Miyanaga, Masahiro Seike, et al.Oncotarget|June 23, 2018
Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancerShinji Nakamichi, Masahiro Seike, Akihiko Miyanaga, et al.Cancers|November 9, 2024
Serum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint InhibitorsKeiki Miyadera, Sho Kakuto, Mayu Sugai, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|October 1, 2020
A Possible, Non-Invasive Method of Measuring Dynamic Lung Compliance in Patients with Interstitial Lung Disease Using PhotoplethysmographyKenichiro Atsumi, Yoshinobu Saito, Toru Tanaka, et al.Anticancer Research|August 5, 2006
Phase I/II study of paclitaxel + carboplatin for refractory or recurrent non-small cell lung cancerAkihiko Gemma, Masahiro Seike, Seiji Kosaihira, et al.International Journal of Oncology|April 10, 2014
Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexedSusumu Takeuchi, Masahiro Seike, Rintaro Noro, et al.Pageof 25